Xuenou > Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant
Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant
Pfizer and BioNTech said that updated data from a Phase 2-3 clinical trial shows the bivalent booster performed better against the BA.4 and BA.5 omicron subvariants.

Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant

Pfizer and BioNTech said that updated data from a Phase 2-3 clinical trial shows the bivalent booster performed better against the BA.4 and BA.5 omicron subvariants.